MUC16 and pancreatic neoplasm: Our LC-MS/MS identified the secreted isoform of MSLN which is capable of binding to CA125/MUC16, a heavily glycosylated membrane-associated protein which is overexpressed on the surface of pancreatic cancer cells [59–62].